Release Summary

Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma

Bristol-Myers Squibb Company and Pharmacyclics, Inc. and Janssen Research & Development, LLC